FRIEDBERG ALBERT

Average Profitability
15.22%
Insider Buys Quantity
29
Insider Buys Sum
$83.96M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of FRIEDBERG ALBERT

According to the SEC Form 4 filings, FRIEDBERG ALBERT, being in a position of

  1. at Vaccinex, Inc.,
    оver the last 12 months, has bought 220309 shares for $1.33M, and sold 0 shares,
    over all time since 2018-08-13, has bought 17559500 shares for $83.96M, and sold 0 shares.

The largest purchase of all time was on 2018-08-13 and amounted to 4916666 shares of Vaccinex, Inc. for $59M.

Biography of FRIEDBERG ALBERT

No biography is available at this moment.

2024-08-09PurchaseVaccinex, Inc.
VCNX
100
0.0062%
$4.51$451+14.19%
2024-08-06PurchaseVaccinex, Inc.
VCNX
2,753
0.1731%
$4.92$13,545+5.06%
2024-08-05PurchaseVaccinex, Inc.
VCNX
3,653
0.2165%
$4.60$16,804+5.82%
2024-08-01PurchaseVaccinex, Inc.
VCNX
11,703
0.7174%
$4.72$55,238+6.69%
2024-07-31PurchaseVaccinex, Inc.
VCNX
200,000
9.6346%
$6.15$1.23M-20.99%
2024-05-30PurchaseVaccinex, Inc.
VCNX
861
0.0604%
$5.20$4,473+7.88%
2024-05-29PurchaseVaccinex, Inc.
VCNX
957
0.0665%
$4.95$4,737+11.8%
2024-04-19PurchaseVaccinex, Inc.
VCNX
282
0.0193%
$4.73$1,334+12.02%
2023-10-03PurchaseVaccinex, Inc.
VCNX
3M
63.8635%
$1.00$3M+429.26%
2022-01-27PurchaseVaccinex, Inc.
VCNX
3.6M
11.2791%
$1.11$4M+15.22%
2020-07-10PurchaseVaccinex, Inc.
VCNX
1.13M
5.0444%
$3.55$4M-35.19%
2020-03-30PurchaseVaccinex, Inc.
VCNX
5,000
0.0316%
$4.06$20,300-13.18%
2020-03-27PurchaseVaccinex, Inc.
VCNX
4,000
0.0257%
$4.18$16,720-14.04%
2020-03-26PurchaseVaccinex, Inc.
VCNX
1,000
0.0063%
$4.44$4,440-20.93%
2020-03-24PurchaseVaccinex, Inc.
VCNX
2,000
0.0135%
$4.40$8,800-14%
2020-03-20PurchaseVaccinex, Inc.
VCNX
2,000
0.0127%
$4.31$8,620-17.41%
2020-03-19PurchaseVaccinex, Inc.
VCNX
4,000
0.0239%
$4.15$16,600-18.78%
2020-03-17PurchaseVaccinex, Inc.
VCNX
3,440
0.0214%
$4.00$13,760-11.47%
2020-03-16PurchaseVaccinex, Inc.
VCNX
600
0.0033%
$4.15$2,490-25.11%
2020-03-13PurchaseVaccinex, Inc.
VCNX
3,000
0.0203%
$4.28$12,840-10.61%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.